AAAAAA
Results:
1-15
|
Results: 15
Bladder preservation in muscle-invasive bladder cancer by conservative surgery and radiochemotherapy
Authors:
Dunst, J
Rodel, C
Zietman, A
Schrott, KM
Sauer, R
Shipley, WU
Citation: J. Dunst et al., Bladder preservation in muscle-invasive bladder cancer by conservative surgery and radiochemotherapy, SEM SURG ON, 20(1), 2001, pp. 24-32
Authors:
Morris, AD
Zietman, AL
Althausen, AF
Heney, NM
Kaufman, DS
Shipley, WU
Citation: Ad. Morris et al., The value of external beam radiation in node positive prostate cancer: a multivariate analysis, UROL ONCOL, 6(6), 2001, pp. 255-260
Authors:
Brown, AL
Zietman, AL
Shipley, WU
Kaufman, DS
Citation: Al. Brown et al., An organ-preserving approach to muscle-invading transitional cell cancer of the bladder, HEMAT ONCOL, 15(2), 2001, pp. 345
Authors:
Zietman, AL
Grocela, J
Zehr, E
Kaufman, DS
Young, RH
Althausen, AF
Heney, NM
Shipley, WU
Citation: Al. Zietman et al., Selective bladder conservation using transurethral resection, chemotherapy, and radiation: Management and consequences of Ta, T1, and Tis recurrence within the retained bladder, UROLOGY, 58(3), 2001, pp. 380-385
Authors:
Shipley, WU
Citation: Wu. Shipley, The Thompson article reviewed, ONCOLOGY-NY, 14(1), 2000, pp. 135-136
Authors:
Zietman, AL
Shipley, WU
Kaufman, DS
Citation: Al. Zietman et al., Organ-conserving approaches to muscle-invasive bladder cancer: future alternatives to radical cystectomy, ANN MED, 32(1), 2000, pp. 34-42
Authors:
Dalesio, O
van Tinteren, H
Clarke, M
Peto, R
Schroder, FH
Dechering, I
Evans, V
Godwin, J
Blumenstein, BA
Crawford, ED
Denis, L
Hall, R
Hill, C
Iversen, P
Shipley, WU
Soloway, M
Sylvester, R
Citation: O. Dalesio et al., Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials, LANCET, 355(9214), 2000, pp. 1491-1498
Authors:
Chakravarti, A
Zehr, EM
Zietman, AL
Shipley, WU
Goggins, WB
Finkelstein, DM
Young, RH
Chang, EL
Wu, CL
Citation: A. Chakravarti et al., Thymosin beta-15 predicts for distant failure in patients with clinically localized prostate cancer - Results from a pilot study, UROLOGY, 55(5), 2000, pp. 635-638
Authors:
Cox, JD
Gallagher, MJ
Hammond, EH
Kaplan, RS
Schellhammer, PF
Crook, JM
Leibel, SA
Forman, JD
Grimm, PD
Zietman, AL
Hudson, MA
Schild, SA
Beyer, DC
Hussey, DH
Thames, H
Shipley, WU
Citation: Jd. Cox et al., Consensus statements on radiation therapy of prostate cancer: Guidelines for prostate re-biopsy after radiation and for radiation therapy with risingprostate-specific antigen levels after radical prostatectomy, J CL ONCOL, 17(4), 1999, pp. 1155-1163
Authors:
Shipley, WU
Kaufman, DS
Citation: Wu. Shipley et Ds. Kaufman, Bladder preservation trial: Radiation Therapy Oncology Group 89-03 - In reply, J CL ONCOL, 17(4), 1999, pp. 1328-1328
Authors:
Zietman, AL
Zehr, EM
Shipley, WU
Citation: Al. Zietman et al., The long-term effect on PSA values of incidental prostatic irradiation in patients with pelvic malignancies other than prostate cancer, INT J RAD O, 43(4), 1999, pp. 715-718
Authors:
Zietman, AL
Shipley, WU
Citation: Al. Zietman et Wu. Shipley, PSA relapse definitions - The Vancouver rules show superior predictive power - In response, INT J RAD O, 43(3), 1999, pp. 700-700
Authors:
Shipley, WU
Thames, HD
Sandler, HM
Hanks, GE
Zietman, AL
Perez, CA
Kuban, DA
Hancock, SL
Smith, CD
Citation: Wu. Shipley et al., Radiation therapy for clinically localized prostate cancer - A multi-institutional pooled analysis, J AM MED A, 281(17), 1999, pp. 1598-1604
Authors:
Shipley, WU
Kaufman, DS
Heney, NM
Althausen, AF
Zietman, AL
Citation: Wu. Shipley et al., An update of combined modality therapy for patients with muscle invading bladder cancer using selective bladder preservation or cystectomy, J UROL, 162(2), 1999, pp. 445-450
Authors:
Raghavan, D
Shipley, WU
Citation: D. Raghavan et Wu. Shipley, Questions and responses, J UROL, 162(2), 1999, pp. 450-451
Risultati:
1-15
|